| Original language | English (US) |
|---|---|
| Pages (from-to) | 1403-1406 |
| Number of pages | 4 |
| Journal | Clinical Journal of the American Society of Nephrology |
| Volume | 17 |
| Issue number | 9 |
| DOIs |
|
| State | Published - Sep 2022 |
ASJC Scopus subject areas
- Epidemiology
- Critical Care and Intensive Care Medicine
- Nephrology
- Transplantation
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinical Journal of the American Society of Nephrology, Vol. 17, No. 9, 09.2022, p. 1403-1406.
Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - The Importance of Transplant Nephrology to a Successful Kidney Transplant Program
AU - Moe, Sharon M.
AU - Brennan, Daniel C.
AU - Doshi, Mona D.
AU - Gaston, Robert S.
AU - Gurley, Susan B.
AU - Mujtaba, Muhammad A.
AU - Schmidt, Rebecca J.
AU - Segal, Mark S.
AU - Tucker, J. Kevin
AU - Wiseman, Alexander C.
AU - Josephson, Michelle A.
N1 - Funding Information: D.C. Brennan reports consultancy agreements with CareDx, Medeor, Sanofi, and Veloxis; research funding from Allovir, Amplyx, CareDx, and Natera; honoraria from CareDx, Sanofi, and Veloxis; and serving in an advisory or leadership role for the editorial board of Transplantation and UpToDate. R.S. Gaston reports employment with CTI Clinical Trial and Consulting, Inc. and ownership interest in AbbVie Pharmaceuticals, Eli Lilly and Co., Merck and Co., Organon and Co., and Pfizer, Inc. S.B. Gurley reports spouse’s employment with United Therapeutics. M.A. Josephson reports consultancy agreements with Exosome Diagnostics, IMMUCOR, Labcorp, Otsuka, UBC Pharmaceutical Support Services for the mycophenolate pregnancy registry, and Vera Therapeutics; ownership interest in Seagen; research funding from Bucksbaum Institute and Gift of Hope; honoraria from ASN for Highlights and the ASN Board Review Course; and serving in an advisory or leadership role for ASN. S.M. Moe reports consultancy agreements with Amgen, Ardelyx, and Sanifit; stock in Eli Lilly; research grants from Chugai, Keryx, and the National Institutes of Health (NIH); honoraria from Amgen, Ardelyx, and Sani-fit; and serving on the editorial boards of American Journal of Nephrology and American Journal of Nutrition. M.A. Mujtaba reports honoraria from CareDx and Mallinckrodt, serving in an advisory or leadership role for Mallinckrodt, serving on the editorial board of Clinical Transplant, and speakers bureau for CareDx. R.J. Schmidt reports research funding from Arbor Research, NIH/the National Institute of Diabetes and Digestive and Kidney Diseases, and Retrophin; reports serving as the past president and a member of the board of directors of the Renal Physicians Association; and is a member of the American Association of Kidney Patients Medical Advisory Board, a member of the Kidney Transplant Collaborative Board of Directors, and a member of the Quality Insights Board of Directors. M.S. Segal reports employment with Malcom Randall Veterans Affairs Medical Center and research funding for a clinical trial with Alexion and a clinical trial with RegenMed. J.K. Tucker reports other interests or relationships as an UpToDate peer reviewer. A.C. Wiseman reports employment with Centura Transplant; consultancy agreements with CareDx, Hansa, Immucor, Meteor, Natera, Nephrosant, and Veloxis; and speakers bureau for CareDx, Sanofi Genzyme, and Veloxis. The remaining author has nothing to disclose.
PY - 2022/9
Y1 - 2022/9
UR - http://www.scopus.com/inward/record.url?scp=85137519734&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137519734&partnerID=8YFLogxK
U2 - 10.2215/CJN.02000222
DO - 10.2215/CJN.02000222
M3 - Comment/debate
C2 - 35914794
AN - SCOPUS:85137519734
SN - 1555-9041
VL - 17
SP - 1403
EP - 1406
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 9
ER -